Fri, December 9, 2011
Thu, December 8, 2011
Wed, December 7, 2011
Tue, December 6, 2011
Mon, December 5, 2011
Sun, December 4, 2011
Fri, December 2, 2011
Thu, December 1, 2011
Wed, November 30, 2011
[ Wed, Nov 30th 2011 ] - Market Wire
Watson Launches Generic LIPITOR
Tue, November 29, 2011
Mon, November 28, 2011
Sun, November 27, 2011
Fri, November 25, 2011
Thu, November 24, 2011
Wed, November 23, 2011
[ Wed, Nov 23rd 2011 ] - Market Wire
Alere Acquires Arriva Medical

SpectraScience to Present at the 4th Annual LD Micro Conference on December 7


//health-fitness.news-articles.net/content/2011/ .. th-annual-ld-micro-conference-on-december-7.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


December 01, 2011 09:00 ET

SpectraScience to Present at the 4th Annual LD Micro Conference on December 7

SAN DIEGO, CA--(Marketwire - Dec 1, 2011) - SpectraScience, Inc. (OTCQB: [ SCIE ]) (PINKSHEETS: [ SCIE ]), a San Diego based medical device company, today announced that Chief Executive Officer Michael Oliver will be presenting at the 4th Annual LD MICRO Growth Conference in Los Angeles on Wednesday, December 7, 2011 at 4:00 p.m. Pacific. The conference is being held at the Luxe Sunset Boulevard Hotel.

LD Micro founder Chris Lahiji stated, "We are excited to host over 100 companies for the first time in our history. What makes us especially proud, however, are all the interesting companies, such as SpectraScience, from our own backyard in southern California that are presenting this year."

"Conferences like the LD MICRO Growth Conference provide an excellent venue for companies like ours to introduce ourselves to investors interested in small cap companies," says SpectraScience CEO Michael Oliver.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.



Publication Contributing Sources